These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9121852)
1. Effectiveness of budesonide aerosol in ventilator-dependent preterm babies: a preliminary report. Arnon S; Grigg J; Silverman M Pediatr Pulmonol; 1996 Apr; 21(4):231-5. PubMed ID: 9121852 [TBL] [Abstract][Full Text] [Related]
2. Trial of beclomethasone dipropionate by metered-dose inhaler in ventilator-dependent neonates less than 1500 grams. Giep T; Raibble P; Zuerlein T; Schwartz ID Am J Perinatol; 1996 Jan; 13(1):5-9. PubMed ID: 8645387 [TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Rozycki HJ; Byron PR; Elliott GR; Carroll T; Gutcher GR Pediatr Pulmonol; 2003 May; 35(5):375-83. PubMed ID: 12687595 [TBL] [Abstract][Full Text] [Related]
4. The efficacy of nebulized budesonide in dexamethasone-treated outpatients with croup. Klassen TP; Watters LK; Feldman ME; Sutcliffe T; Rowe PC Pediatrics; 1996 Apr; 97(4):463-6. PubMed ID: 8632929 [TBL] [Abstract][Full Text] [Related]
5. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. Wolthers OD; Pedersen S Pediatrics; 1992 May; 89(5 Pt 1):839-42. PubMed ID: 1579391 [TBL] [Abstract][Full Text] [Related]
6. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group. Piquet J; Zuck P; Dennewald G; Dugue P; Grivaux M; Brun P; Severac JC; Ostinelli J; Cheeseman KH Adv Ther; 1996; 13(1):38-50. PubMed ID: 10172710 [TBL] [Abstract][Full Text] [Related]
7. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML; Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872 [TBL] [Abstract][Full Text] [Related]
8. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler. Murphy K; Noonan M; Silkoff PE; Uryniak T Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler. Toogood JH; White FA; Baskerville JC; Fraher LJ; Jennings B J Allergy Clin Immunol; 1997 Feb; 99(2):186-93. PubMed ID: 9042043 [TBL] [Abstract][Full Text] [Related]
10. Morphine does not provide adequate analgesia for acute procedural pain among preterm neonates. Carbajal R; Lenclen R; Jugie M; Paupe A; Barton BA; Anand KJ Pediatrics; 2005 Jun; 115(6):1494-500. PubMed ID: 15930209 [TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children. White MV; Cruz-Rivera M; Walton-Bowen K Fam Med; 1999 May; 31(5):337-45. PubMed ID: 10407712 [TBL] [Abstract][Full Text] [Related]
12. Nebulized budesonide for children with mild-to-moderate croup. Klassen TP; Feldman ME; Watters LK; Sutcliffe T; Rowe PC N Engl J Med; 1994 Aug; 331(5):285-9. PubMed ID: 8022437 [TBL] [Abstract][Full Text] [Related]
13. Influence of topical steroid treatment on maxillary sinusitis. Qvarnberg Y; Kantola O; Salo J; Toivanen M; Valtonen H; Vuori E Rhinology; 1992 Jun; 30(2):103-12. PubMed ID: 1411095 [TBL] [Abstract][Full Text] [Related]
14. Inhaled budesonide for maintenance treatment of pulmonary sarcoidosis. Selroos O; Löfroos AB; Pietinalho A; Niemistö M; Riska H Sarcoidosis; 1994 Sep; 11(2):126-31. PubMed ID: 7809497 [TBL] [Abstract][Full Text] [Related]
15. Inhaled budesonide in ventilator-dependent preterm infants: a randomized, double-blind pilot study. Merz U; Kusenbach G; Häusler M; Peschgens T; Hörnchen H Biol Neonate; 1999; 75(1):46-53. PubMed ID: 9831683 [TBL] [Abstract][Full Text] [Related]
16. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis. Alberts C; van der Mark TW; Jansen HM Eur Respir J; 1995 May; 8(5):682-8. PubMed ID: 7656936 [TBL] [Abstract][Full Text] [Related]
17. Budesonide delivered by dosimetric jet nebulization to preterm very low birthweight infants at high risk for development of chronic lung disease. Jónsson B; Eriksson M; Söder O; Broberger U; Lagercrantz H Acta Paediatr; 2000 Dec; 89(12):1449-55. PubMed ID: 11195235 [TBL] [Abstract][Full Text] [Related]
18. Delivery of micronized budesonide suspension by metered dose inhaler and jet nebulizer into a neonatal ventilator circuit. Arnon S; Grigg J; Nikander K; Silverman M Pediatr Pulmonol; 1992 Jul; 13(3):172-5. PubMed ID: 1437332 [TBL] [Abstract][Full Text] [Related]